Clinical trial
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a…
NCT00253513 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00253513 |
|---|---|
| Title | Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome |
| Official title | A Study of a Reduced-Intensity Conditioning Regimen With Treosulfan and Fludarabine for Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Leukemia |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | medac GmbH Industry National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug, Procedure |
| Interventions | fludarabine, treosulfan, allogeneic blood or bone marrow transplantation |
| Enrollment | 60 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Nov 15, 2005 |
| Last update posted | Jun 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: